Literature DB >> 12163993

Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia.

Karl-Titus Hoffmann1, Beate Rau, Peter Wust, Christian Stroszczynski, Michael Hünerbein, Ulrike Schneider, Roland Felix.   

Abstract

BACKGROUND: The restaging accuracy of MR imaging in advanced primary rectal carcinoma after preoperative radiochemotherapy and regional hyperthermia was evaluated and compared with the histopathologically verified degree of tumor remission after a course of radio-chemo-thermotherapy. PATIENTS AND METHODS: 35 patients with primary rectal carcinoma (uT3/uT4) underwent MRI using a surface coil 4-6 weeks after radiochemotherapy (n = 35), regional hyperthermia (n = 23), and before curative surgery. We defined as gold standard for the remission status the comparison of pretherapeutic endosonography with the histopathology of the resected specimen.
RESULTS: T category was correctly restaged after preoperative treatment in only 19 (54%) of 35 patients. Nine of 20 responders were overstaged and seven of 15 non-responders were understaged. Concurrently, the N category was correctly restaged in 19 (54%) of 35 patients (twelve responders and seven non-responders). Overstaging occurred in four responders and two non-responders, understaging occurred in four responders and six non-responders.
CONCLUSIONS: MRI proved independent of the response status as not suitable to restage locally advanced rectal carcinoma after preoperative radiochemotherapy despite optimized imaging technique and spatial resolution. Basically, imaging the morphology of a tumor cannot clearly differentiate between vital and devitalized tissue after a treatment. Functional imaging such as PET (positron emission tomography) appears more feasible for restaging after radio-chemo-thermotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12163993     DOI: 10.1007/s00066-002-0938-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  15 in total

1.  Quality assurance for clinical studies in regional deep hyperthermia.

Authors:  Gregor Bruggmoser; Stefan Bauchowitz; Richard Canters; Hans Crezee; Michael Ehmann; Johanna Gellermann; Ulf Lamprecht; Nicoletta Lomax; Marc Benjamin Messmer; Oliver Ott; Sultan Abdel-Rahman; Rolf Sauer; Manfred Schmidt; Andreas Thomsen; Rüdiger Wessalowski; Gerard van Rhoon
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

2.  Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia.

Authors:  G Bruggmoser; S Bauchowitz; R Canters; H Crezee; M Ehmann; J Gellermann; U Lamprecht; N Lomax; M B Messmer; O Ott; S Abdel-Rahman; M Schmidt; R Sauer; A Thomsen; R Wessalowski; G van Rhoon
Journal:  Strahlenther Onkol       Date:  2012-09       Impact factor: 3.621

Review 3.  Gesture as representational action: A paper about function.

Authors:  Miriam A Novack; Susan Goldin-Meadow
Journal:  Psychon Bull Rev       Date:  2017-06

4.  Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

Authors:  Jihyun Park; Kyoung Jin Chang; Young Seok Seo; Byung Hyun Byun; Joon Ho Choi; Hansol Moon; Ilhan Lim; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2014-08-01

5.  Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.

Authors:  Koji Yasuda; Eiji Sunami; Kazushige Kawai; Hirokazu Nagawa; Joji Kitayama
Journal:  J Gastrointest Cancer       Date:  2012-06

6.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?

Authors:  T Denecke; B Rau; K-T Hoffmann; B Hildebrandt; J Ruf; M Gutberlet; M Hünerbein; R Felix; P Wust; H Amthauer
Journal:  Eur Radiol       Date:  2005-04-02       Impact factor: 5.315

7.  MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry.

Authors:  Michael R Torkzad; Johan Lindholm; Anna Martling; Björn Cedermark; Bengt Glimelius; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2007-01-31       Impact factor: 5.315

8.  Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.

Authors:  Holger Amthauer; Timm Denecke; Beate Rau; Bert Hildebrandt; Michael Hünerbein; Juri Ruf; Ulrike Schneider; Matthias Gutberlet; Peter M Schlag; Roland Felix; Peter Wust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

9.  Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer.

Authors:  Yong Beom Cho; Ho-Kyung Chun; Min Ju Kim; Joon Young Choi; Chi-Min Park; Byung-Tae Kim; Soon Jin Lee; Seong Hyeon Yun; Hee Cheol Kim; Woo Yong Lee
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

10.  Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Authors:  Carlo Capirci; Lucia Rampin; Paola A Erba; Fabrizio Galeotti; Giorgio Crepaldi; Elena Banti; Marcello Gava; Stefano Fanti; Giuliano Mariani; Pier Carlo Muzzio; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.